BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:SHY-ONC6 readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of SHY-ONC6\, from ClinicalTrials.gov estima
 tes.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07705334-2728@assetmemo.bio
DTSTAMP:20261121T005701Z
DTSTART;VALUE=DATE:20270515
DTEND;VALUE=DATE:20270516
SUMMARY:SHY-ONC6: Phase 1 readout est. (NCT07705334)
DESCRIPTION:SHY-ONC6\, phase 1\, Non-Small Cell Lung Cancer.\nStudy: A Stud
 y of SHY-ONC6\, a Novel Proteasome Inhibitor\, in Adults With Advanced or 
 Metastatic Solid Tumors\nEstimated primary completion: 15 May 2027. This i
 s a ClinicalTrials.gov estimate\, not a confirmed readout date\, and it ca
 n move.\nDrug page: https://assetmemo.bio/drug/shy-onc6#upcoming-events\nR
 egistry record: https://clinicaltrials.gov/study/NCT07705334
URL:https://assetmemo.bio/drug/shy-onc6#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
